REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 428 filers reported holding REPLIGEN CORP in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,763,637 | +7.3% | 118,003 | -4.5% | 0.40% | +14.5% |
Q2 2023 | $17,485,353 | -20.2% | 123,606 | -5.0% | 0.34% | -22.6% |
Q1 2023 | $21,912,485 | +0.3% | 130,153 | +0.8% | 0.45% | -9.2% |
Q4 2022 | $21,851,994 | -17.4% | 129,065 | -8.7% | 0.49% | -19.6% |
Q3 2022 | $26,459,000 | +13.6% | 141,413 | -1.4% | 0.61% | +14.0% |
Q2 2022 | $23,290,000 | -13.8% | 143,409 | -0.1% | 0.54% | +2.7% |
Q1 2022 | $27,013,000 | -18.4% | 143,619 | +14.9% | 0.52% | -2.2% |
Q4 2021 | $33,115,000 | -2.6% | 125,037 | +6.3% | 0.53% | -7.3% |
Q3 2021 | $33,995,000 | +37.8% | 117,633 | -4.8% | 0.58% | +43.3% |
Q2 2021 | $24,662,000 | -0.9% | 123,548 | -3.4% | 0.40% | -5.4% |
Q1 2021 | $24,875,000 | -17.8% | 127,952 | -19.0% | 0.42% | -17.2% |
Q4 2020 | $30,258,000 | +16.0% | 157,901 | -10.7% | 0.51% | -4.6% |
Q3 2020 | $26,074,000 | +30.1% | 176,723 | +9.0% | 0.54% | +24.0% |
Q2 2020 | $20,038,000 | +148.3% | 162,104 | +93.9% | 0.43% | +88.7% |
Q1 2020 | $8,071,000 | – | 83,602 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |